University of Iowa Pharmaceuticals Revenue and Competitors

University of Iowa Pharmaceuticals (UIP) is the largest and most experienced university-affiliated FDA-registered pharmaceutical manufacturing facility in the United States. UIP has been developing formulations, manufacturing products, and conducting analytical testing in compliance with cGMPs for almost 40 years. During the past 5 years UIP has manufactured over 1100 batches of product for over 100 different sponsors. UIP serves a broad spectrum of clients of all sizes in the pharmaceutical and biotechnology industries and has performed work for pharmaceutical companies throughout the United States and the world. Additionally, UIP has performed work for numerous government agencies, including the National Cancer Institute, the Centers for Disease Control, and the National Institutes of Health. UIP is capable of producing most types of pharmaceutical dosage forms. These dosage forms include sterile injectable solutions; sterile lyophilized (freeze-dried) powders; topical and oral solutions, emulsions, and suspensions; tablets (uncoated and film or functional coated); and hard gelatin capsules (powder or hot melt filled). UIP is compliant with 21 CFR parts 11, 210, and 211, licensed by the Drug Enforcement Agency (DEA) to handle controlled substances (Schedules I - V) and capable of handling potent/cytotoxic materials. UIP has produced numerous products for use in the European Union (EU) and passed numerous Qualified Person (QP) audits. Formulation Development, Clinical Supply Manufacturing, Analytical Testing Services, Small Scale Commerical Manufacturing, Analytical Method Development and Validation, Stability Studies, Sterile Filling, API Release Testing, Tablets and Capsules, Lyophilization